A three-year-old Oliver (Ollie) Chu has become the world’s first patient to receive a revolutionary stem cell gene therapy for Hunter syndrome. This rare, progressive, inherited disorder damages the ...

GLP-1 is the naturally produced hormone whose function is being mimicked by drugs like semaglutide and tirzepatide, the active ingredients in popular and highly effective weight-loss drugs like Wegovy ...

Scientists have discovered that a “longevity gene” found in people over 100 years old can protect the heart from the effects of Progeria, a rare genetic disorder that causes children to age rapidly.

WINFIELD, Kan. (KSNW) — It’s been over a decade since Jim Helmer coached a cross-country program. After seven years at Winfield and over three decades at Southwestern College, Helmer called it a ...

After more than a decade working behind the scenes as a makeup artist, Billie Gene is stepping into the spotlight with a new beauty venture of his own. Insert: Billie Gene Body. Gene—known for ...

Gene editing has made huge leaps in recent years, such as treating the congenital blood disorders sickle cell anemia and beta thalassemia, which can require lifelong blood transfusions. But scientists ...

Intellia Therapeutics, Inc.'s lead gene-editing therapies, Lonvo-z and Nex-z, show best-in-class potential with 'one and done' treatment and strong early efficacy and safety data. Recent safety ...

When individuals begin paying attention to their nonverbal cues — not just those of others — they gain insight into what they’re feeling and why. Leaders who tune into their own body language first ...

Scientists have decoded the sea spider’s genome for the first time, revealing how its strangely shaped body—with organs in its legs and barely any abdomen—may be tied to a missing gene. The detailed ...

INDIANAPOLIS — It took the Knicks 97 games to figure out what the rest of the basketball world could see — that Karl-Anthony Towns, one of the NBA’s most talented and prolific offensive threats at the ...

Both REQORSA Alone and in Combination with LUMAKRAS ® Demonstrated Robust Anti-Tumor Effects in Ras Inhibitor Resistant Non-Small Cell Lung Cancer AUSTIN, Texas, April 30, 2025 /PRNewswire/ -- Genprex ...

AUSTIN, Texas, March 26, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...